The price of Sotorasib varies significantly depending on the region, purchase channel, and dosage. The specific price should be confirmed with the hospital or authorized pharmacy. This is a prescription drug and must be used strictly according to your doctor's instructions. Genetic testing is required before starting this medication to confirm eligibility for the indication (e.g., for non-small cell lung cancer patients with KRAS G12C mutations).
Main Factors Affecting Price
Original Drug vs. Generic Drug: Original drugs (such as Lumakras developed by Amgen) are more expensive. Generic drugs may be available in some countries or regions at relatively lower prices, but the compliance and safety of generic drugs should be carefully considered.
Health Insurance Policy: Some regions may include Sotorasib in their health insurance coverage, significantly reducing out-of-pocket expenses for patients. It is recommended to consult your local health insurance department or hospital.
Drug Dosage: Different dosages (e.g., 120mg × 240 tablets/box) or packaging specifications will affect the total price and should be selected based on the treatment cycle.
Precautions for Use
Use as directed by your doctor: A prescription must be issued after an assessment of your condition by an oncologist. Do not adjust the dosage or discontinue the medication on your own.
Side effect monitoring: Common side effects include diarrhea and elevated liver enzymes, requiring regular liver and kidney function checks.
Purchase channels: It is recommended to purchase from hospitals or reputable pharmacies to avoid counterfeit drugs through unofficial channels.
Other cost-related advice
If financial burden is significant, assistance can be provided through clinical trials, charitable drug donation programs, etc. Some pharmaceutical companies or foundations offer support to eligible patients. Furthermore, follow-up procedures such as imaging examinations are necessary during medication; overall treatment costs should be planned in advance.
